Posted on October 31, 2009
Filed Under Acne | Leave a Comment
La Roche-Posay's Effaclar AI Intensive Acne Spot Treatment is available to reduce stubborn and inflammatory acne in as few as 3 days. The formulation includes a 5.5% concentration of micronized benzoyl peroxide to clear inflammatory acne, as well as 0.4% LHA (lipohydroxy acid), which is a lipophilic derivative of salicylic acid that micro-exfoliates the skin and stimulates cell renewal to help even the skin tone, including residual skin marking. The product is oil free and noncomedogenic, and has been tested on sensitive skin. (Source: Skin and Allergy News)
Posted on October 29, 2009
Filed Under Acne | Leave a Comment
Authors: Layton AM, Eady EA
PMID: 19857206 [PubMed - in process] (Source: The British Journal of Dermatology)
Posted on October 29, 2009
Filed Under Acne | Leave a Comment
SAN DIEGO (MedPage Today) -- Use of the acne medication isotretinoin (Accutane) is associated with an increased risk of inflammatory bowel disease, researchers said here. (Source: MedPage Today Gastroenterology)
Posted on October 28, 2009
Filed Under Acne | Leave a Comment
Dermatologica 1948;95:91-101 (DOI:10.1159/000255936) (Source: Dermatology)
Posted on October 27, 2009
Filed Under Acne | Leave a Comment
Authors: Schwartz GS, Rios L, Zivin-Tutela T, Bhora FY, Connery CP
A rare but important constellation of musculoskeletal and cutaneous symptoms, including synovitis, acne, pustulosis, hyperostosis, and osteitis, has recently been designated the SAPHO syndrome. The exact etiology is unknown, although various infectious agents have been proposed. The most common site of osteoarticular involvement is the sternoclavicular joint, and therefore, recognition of this syndrome and appropriate workup and management is crucial in the differential diagnosis of an anterior chest wall mass.
PMID: 19853079 [PubMed - in process] (Source: The Annals of Thoracic Surgery)
« go back —
keep looking »